PIK3CG and asthma: In the present study, LY294002, a PI3K/AKT pathway inhibitor, reversed the effects of diazoxide on the proliferative ability of ASMCs in the asthma rat model, indicating that the PI3K/AKT pathway may be involved in the proliferative ability of ASMCs and the progression of asthma.